Bob Greene
Managing Partner & Co-Founder @ Contour Venture Partners
New City, United States
Bob Greene is a Series A investor at Contour Venture Partners in New City focused on Software and Financial Services. Bob Greene is based out of New City, New York and is the Managing Partner & Co-Founder of Contour Venture Partners. Bob previously worked at Flatiron Partners as a Co-Managing Partner. Bob Greene attended the MIT Sloan School of Management.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Bob Greene invests in
Stages Bob Greene invests in
Countries Bob Greene invests in
Round sizes
Round size
- Series A
- $2.1M–$20M
Investment Focus
Industry
- Software 5 (42%)
- Financial Services 3 (25%)
- Artificial Intelligence 3 (25%)
- SaaS 2 (17%)
- Video 2 (17%)
Stage
- Series A 5 (42%)
- Seed 4 (33%)
- Series B 1 (8%)
- Funding Round 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Overalls
|
95% of businesses have faced disruption in the past two years—a 3x increase in five years. In this age of disruption, employees lose 6.5 hours weekly to disasters, distractions, and disruptions, draining productivity and increasing stress. Overalls helps employees stay focused by handling everything from childcare searches to denied insuranceclaims and crisis recovery. By reducing stress and reclaiming time, Overalls boosts business performance and employee well-being. Leading companies including Better Business Bureau, Epic Group, and University of the Pacific trust Overalls to support their business—driving productivity and a great employee culture. | Seed / Jun 10, 2024 | |
Overalls
|
95% of businesses have faced disruption in the past two years—a 3x increase in five years. In this age of disruption, employees lose 6.5 hours weekly to disasters, distractions, and disruptions, draining productivity and increasing stress. Overalls helps employees stay focused by handling everything from childcare searches to denied insuranceclaims and crisis recovery. By reducing stress and reclaiming time, Overalls boosts business performance and employee well-being. Leading companies including Better Business Bureau, Epic Group, and University of the Pacific trust Overalls to support their business—driving productivity and a great employee culture. | $5M / Seed / Jun 10, 2024 | |
Leal Health
|
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to executepatient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn. | $20M / Series A / Feb 07, 2022 | |
|
Leal Health
|
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to executepatient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn. | $5M / Series A / Feb 22, 2021 | |
|
Leal Health
|
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to executepatient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn. | $2.7M / Seed / Dec 17, 2019 | |
Radius Networks
|
Radius Networks is a provider of mobile proximity technologies used by app developers, major retailers, restaurant chains, sports complexes, and other brick-and-mortar operators to generate customer traffic analytics and drive innovative customer engagements.Their technologies leverage the wireless signals of mobile devices, such as WiFi,Bluetooth, and GPS, to detect when visitors are in close proximity to important points-of-interest and use this information to provide a better understanding of customer shopping patterns and behaviors and to enable customer engagement in more meaningful and relevant ways.It was founded in 2011 and is headquartered in Washington, District of Columbia. | $15M / Series A / Aug 11, 2019 | |
TruMarx Data Partners
|
TruMarx Data Partners designed and manages COMET, a virtual private market that allows energy market transactors (“ETs”) to electronically negotiate and execute customized, bilateral, structured OTC transactions. The platform creates a one-to-many Request-For-Price process, which leads to a one-to-one, confidential negotiation in a controlled andauditable forum. There are over 275 COMET subscribers that can transact custom energy contracts. | $7.2M / Oct 10, 2018 | |
Source3
|
Source3 is the world’s first platform for end-to-end management of intellectual property in user-generated content (UGC). We provide IP recognition, licensing and rights administration services to connect creators, marketplaces and brands and enable monetization of user content across physical and digital products. Our team has built successfullicensing platforms powering digital music, user-generated videos and 3D printing. Source3 offers scalable, turn-key solutions for today’s global licensing challenges. | $4M / Seed / Sep 15, 2015 | |
Estimize
|
Estimize is an online crowdsourcing platform that shares and reviews fundamental financial estimates from independent, buy-side, and sell-side analysts, along with those of private investors and students. It acts as an online community and discussion forum for hedge funds and asset management professionals to interact and get a true view of marketexpectations. Estimize is also available on major financial research platforms such as Bloomberg, Quantopian, and more. The platform was launched in 2011 and its operations are based in New York, United States. | $3.6M / Series B / Jul 15, 2015 | |
Edgecase (formerly Compare Metrics)
|
Edgecase (formerly Compare Metrics) is the platform behind today’s most inspiring shopping experiences. By allowing shoppers to communicate their unique preferences, context and shopping style, we empower them to discover products on their own terms.Using a proprietary combination of machine learning and human content curation, the Edgecaseplatform enables shopping experiences as unique as the brands we work with. Our solutions integrate new and evolving layers of merchandising data to fuel product discovery, omni-channel engagement and online experiences that today's shoppers crave.Edgecase was founded in 2012 and is based in Austin, Texas. Our team is made up of experts in retail technology, machine learning and natural language processing. Together, we’re committed to creating memorable shopping experiences and propelling what's next in retail. Forward-thinking retailers using Edgecase include: Crate and Barrel, Golfsmith, Kate Somerville, Rebecca Minkoff, Urban Decay, and The Wasserstrom Company. | $4.2M / Series A / May 21, 2013 | |
| See all 12 investments → | |||
Co-Investors
About Contour Venture Partners
Contour Venture Partners invests in companies focused on information technology, and the application of innovative software solutions into the enterprise SaaS, vertical B2B SaaS and financial services sectors. The principals at Contour have a long and successful track record, having directly supported over 85 companies through numerous marketcycles.We take great pride in the strong bonds we form with management teams, as this is a crucial ingredient to achieving long term milestones while also making the process engaging and enjoyable. We recognize it is the details and pursuit of flawless execution combined with the right long-term vision that makes a company great. We have the experience, intuition, judgment and industry expertise to ensure that the foundation is in place for management to build a great business with a sustainable competitive advantage.
Contour Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bob Greene
Managing Partner & Co-Founder
|
|||
Owen Davis
General Partner
|
|||
Matt Gorin
Managing Partner & Co-Founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Bob Greene invest in?
Bob Greene invests primarily in Software, Financial Services and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Bob Greene's check size?
Bob Greene typically joins rounds of $2.1M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bob Greene participates in.
When did Bob Greene last invest?
The most recent investment recorded for Bob Greene closed in Jun 2024. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
